[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content
Log in

Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Gemcitabine potential myotoxicity has been described in several cases of radiation recall and in patients treated with gemcitabine alone or in combination with other chemotherapy agents. We report two cases of gemcitabine related myositis identified at our institution, and perform a literature review of cases which meet the criteria for gemcitabine induced myositis associated to either radiation therapy or chemotherapy alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ardavanis AS, Ioannidis GN, Rigatos GA (2005) Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel. Anticancer Res 25:523–525

    PubMed  Google Scholar 

  2. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100

    Article  PubMed  CAS  Google Scholar 

  3. Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363–367

    Article  PubMed  CAS  Google Scholar 

  4. Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A (1998) Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 50:764–767

    PubMed  CAS  Google Scholar 

  5. Kida Y, Maeshima E, Furukawa K, Ichikawa T, Goda M, Ichinose M (2007) A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer. Mod Rheumatol 17:262–264

    Article  PubMed  Google Scholar 

  6. Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982

    Article  PubMed  CAS  Google Scholar 

  7. Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N (2004) Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 100:1793–1799

    Article  PubMed  Google Scholar 

  8. Ganem G, Solal-Celigny P, Joffroy A, Tassy D, Delpon A, Dupuis O (2000) Radiation myositis: the possible role of gemcitabine. Ann Oncol 11:1615–1616

    Article  PubMed  CAS  Google Scholar 

  9. Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R (2002) Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 53:394–400

    Article  PubMed  Google Scholar 

  10. Miura G, Matsumoto T, Tanaka N, Emoto T, Kawamura T, Matsunaga N (2003) Two cases of radiation myositis probably induced by recall phenomenon. Nippon Igaku Hoshasen Gakkai Zasshi 63:420–422

    PubMed  Google Scholar 

  11. Welsh JS, Torre TG, DeWeese TL, O’Reilly S (1999) Radiation myositis. Ann Oncol 10:1105–1108

    Article  PubMed  CAS  Google Scholar 

  12. Fogarty G, Ball D, Rischin D (2001) Radiation recall reaction following gemcitabine. Lung Cancer 33:299–302

    Article  PubMed  CAS  Google Scholar 

  13. Pinson PJ, Griep C, Sanders WH, Lelie B (2006) Myositis as a ‘radiation-recall phenomenon’ following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma. Ned Tijdschr Geneeskd 150:1891–1894

    PubMed  CAS  Google Scholar 

  14. Fakih MG (2006) Gemcitabine-induced rectus abdominus radiation recall. JOP 7:306–310

    PubMed  Google Scholar 

  15. Squire S, Chan M, Feller E, Mega A, Gold R (2006) An unusual case of gemcitabine-induced radiation recall. Am J Clin Oncol 29:636

    Article  PubMed  Google Scholar 

  16. Horan G, Smith SL, Podd TJ (2006) Gemcitabine-induced radiation necrosis of the pectoralis major muscle. Clin Oncol (R Coll Radiol) 18:85

    Article  CAS  Google Scholar 

  17. O’Regan KN, Nishino M, Armand P, Kelly PJ, Hwang DG, Di Salvo D (2010) Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature. J Ultrasound Med 29:1499–1502

    PubMed  Google Scholar 

  18. Voorburg AM, van Beek FT, Slee PH, Seldenrijk CA, Schramel FM (2002) Vasculitis due to gemcitabine. Lung Cancer 36:203–205

    Article  PubMed  CAS  Google Scholar 

  19. Kalmadi S, McNeill G, Davis M, Peereboom D, Adelstein D, Mekhail T (2006) Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer. Med Oncol 23:507–513

    Article  PubMed  CAS  Google Scholar 

  20. Vatca M, Tejwani S, Yates T (2009) Ischemic myositis in a diabetic patient receiving chemotherapy. Community oncol 6:69

    Google Scholar 

  21. Syrios J, Kechagias G, Xynos ID, Gamaletsou MN, Papageorgiou A, Agrogiannis G, Tsavaris N (2011) Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC Gastroenterol 11:33

    Article  PubMed  Google Scholar 

  22. Wong KM, Khanna M, Wu RC, Hedley DW (2011) Gemcitabine-induced acute myositis in a patient with duodenal cancer. Clin Oncol (R Coll Radiol). doi:10.1016/j.clon.2011.02.007

  23. Burris HA, Hurtig J 3rd (2010) Radiation recall with anticancer agents. Oncologist 15:1227–1237

    Article  PubMed  CAS  Google Scholar 

  24. Hughes BG, Stuart-Harris R (2005) Docetaxel-induced myositis: report of a novel side-effect. Intern Med J 35:369–370

    Article  PubMed  CAS  Google Scholar 

  25. Freilich RJ, Balmaceda C, Seidman AD, Rubin M, DeAngelis LM (1996) Motor neuropathy due to docetaxel and paclitaxel. Neurology 47:115–118

    PubMed  CAS  Google Scholar 

  26. Semb KA, Aamdal S, Oian P (1998) Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 16:3426–3432

    PubMed  CAS  Google Scholar 

  27. Geffen DB, Horowitz J (2000) Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone. Isr Med Assoc J 2:552–553

    PubMed  CAS  Google Scholar 

  28. Aapro MS, Martin C, Hatty S (1998) Gemcitabine—a safety review. Anticancer Drugs 9:191–201

    Article  PubMed  CAS  Google Scholar 

  29. Azzoli CG, Miller VA, Ng KK, Krug LM, Hensley ML, O’Reilly EM, Muller RJ, Kris MG (2003) Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature. Am J Clin Oncol 26:247–251

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr Jerome B. Posner for his advice and extremely valuable suggestions. We thank Judith Lampron for her editorial assistance.

Conflict of interest

The authors report no relevant conflict of interest

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adília Hormigo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pentsova, E., Liu, A., Rosenblum, M. et al. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol 106, 15–21 (2012). https://doi.org/10.1007/s11060-011-0672-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0672-8

Keywords